Adrienne B Shannon

15PUBLICATIONS
5CO-AUTHORS
Epidemiological modellingMedical mycologyApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Disease surveillancePredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (15)

|Jul 28, 2025
Analysis of the Incidence of Lymph Node Metastases in High-Risk Early Stage (T1) Esophageal Adenocarcinomas: A Single-Institution Experience.

Adrienne B Shannon, Marwa A Mohammed, Gregory Y Lauwers

|Jul 13, 2024
Clinical Characteristics and Special Considerations in the Management of Rare Melanoma Subtypes.

Adrienne B Shannon, Jonathan S Zager, Matthew C Perez

|Jun 19, 2024
Intralesional and Infusional Updates for Metastatic Melanoma.

Michelle M Dugan, Adrienne B Shannon, Danielle K DePalo

|Aug 19, 2022
Impact of the affordable care act's medicaid expansion on presentation stage and perioperative outcomes of colorectal cancer.

Cimarron E Sharon, Yun Song, Richard J Straker

|Jul 22, 2022
An Internally Validated Prognostic Risk-Score Model for Disease-Specific Survival in Clinical Stage I and II Merkel Cell Carcinoma.

Adrienne B Shannon, Richard J Straker, Michael J Carr

|Oct 27, 2021
The impact of hospital volume on racial disparities in resected rectal cancer.

Adrienne B Shannon, Richard J Straker, Luke Keele

Pageof 3